AzTrials
AzTrials

Adjustment DisordersZIELNCT03379155

Internet-based Self-help for Negative Life Events

A study testing Internet-based self-help program in people with Adjustment Disorders, run by University of Bern at 2 sites in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study is to investigate the efficacy of an internet-based self-help intervention for dealing with stressful life events. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Adjustment Disorders
What is being tested?
Internet-based self-help program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
98 participants
Where
2 sitesSwitzerland
Study dates
1 Jan 2018to 1 Mar 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Negative life event in a period between two weeks and two years before the study
  • Internet account
  • Sufficient German language skills
  • Informed consent

Who cannot join

  • Persons with moderate or severe depressive symptoms
  • Acute suicidality
  • Psychotic disorder, bipolar disorder
  • Severe, acute mental or physical disorder

Trial locations and contacts

2 sites in 1 country.

Switzerland2 sites
  • University of Bern

    Bern, 3012

  • Universität Zürich

    Zurich, 8050

Other trials in Switzerland

About this study

Official title: ZIEL - Zurück Ins Eigene Leben - Internet-based Self-help for Negative Life Events

The purpose of the study is to investigate the efficacy of an internet-based self-help intervention for dealing with stressful life events.

Read the detailed description

The purpose of the study is to investigate the efficacy of an internet-based self-help intervention for dealing with stressful life events compared to a waiting list, in a randomized controlled trial design. Assessments are at baseline, 4-week and 3 months post-randomization. After 4 weeks, participants in the waiting control group get also access to the intervention.

Being tested
Internet-based self-help program
Medical subject headings
Adjustment Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Internet-based self-help programOther

    The intervention provided is based on the principles of cognitive behavioral therapy (CBT) (Bachem \& Maercker, 2013). The manual integrates a variety of approaches validated as treatments for PTSD, anxiety disorders, or depression; the selection focuses on exercises which are intended to target the main symptoms of AjD, namely preoccupations (e.g. constant rumination, excessive worry about the stressor) and failure to adapt (e.g. sleep disturbance, difficulties concentrating, loss of interest in previously enjoyable activities).

Study groups in NCT03379155
Study groupRoleWhat they receive
Active GroupExperimentalInternet-based self-help
Receives: Other: Internet-based self-help program
Waiting List GroupNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adjustment Disorder - New Module 20 (ADNM-20)

    The ADNM-20 is a self-report assessment for adjustment disorder. It is aimed at adults who feel burdened by a critical life event.

    The ADNM-20 consists of two parts: an event list for recording stress and an item list for recording the resulting symptoms. In the event list, all burdens during the last two years are recorded and the subjectively highest burdens are named. On the basis of the item list, preoccupations and mismatch, the main symptom groups of the adaptation disorder according to ICD-11, as well as the concomitant symptoms of avoidance, depressiveness, anxiety, impulse control problems and functional impairment are recorded.

    The scale ranges from 0 (no stress) to 80 (high exposure).

    Measured: 4-week

Secondary outcomes (7)
  1. Brief Symptom Inventory - Short Version (BSI-18)

    The short version of the Brief Symptom Inventory (BSI-18) is an easily applicable, reliable and valid self-report measure in wide international use. It assesses the syndromes of somatisation, depression and anxiety by means of 6 items each.

    The global factor ranges from 0 (no symptoms) to 72 (high symptomatic burden).

    Measured: 4-week

  2. Beck Depression Inventory (BDI)

    The BDI is a 21-question multiple-choice self-report inventory, one of the most widely used psychometric tests for measuring the severity of depression.

    The score ranges from 0 (no symptoms) to 63 (severe depression).

    Measured: 4-week

  3. Short Form 12-Item Survey (SF-12)

    The SF-12 consists of 12 questions and is a general health questionnaire that provides information on the patient's state of health in more than 8 different dimensions.

    Physical and Mental Health Composite Scores (PCS \& MCS) are computed using the scores of twelve questions and range from 0 to 100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health.

    Measured: 4-week

  4. Sense of Coherence Questionaire Revised (SOC-R)

    The SOC-R is a new conceptualization and operationalization of the resilience indicator SOC.

    The total score ranges from 13 (low) to 65 (high SOC).

    Measured: 4-week

  5. Questionnaire for measuring patient satisfaction (ZUF-8)

    The ZUF-8 is a self-assessment tool to assess the patient's satisfaction with regard to aspects of the clinic and treatment.

    The scale ranges from 8 (bad) to 32 (good satisfaction).

    Measured: 4-week

  6. Credibility/Expectancy Questionaire (CEQ)

    The CEQ is a scale for measuring treatment expectancy and rationale credibility for use in clinical outcome studies.

    The CEQ utilizes two scales during the administration (1-9, and 0-100%).

    Measured: 4-week

  7. System Usability Scale (SUS)

    The System Usability Scale (SUS) is a simple and technology-independent questionnaire to evaluate the usability of a system.

    The score ranges from 0 (worst) to 100 (best).

    Measured: 4-week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Dec 2017
  2. Study start1 Jan 2018
  3. Primary completion1 Feb 2019
  4. Study completion1 Mar 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized controlled trial design, comparing to a waitling list
Masking
None (open label)
Enrolment
98 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03379155
Sponsor's protocol ID
ZIEL
Acronym
ZIEL
Status last verified
Oct 2019
First submitted
14 Dec 2017
Last updated
14 Oct 2019
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Internet-based self-help program in people with Adjustment Disorders, run by University of Bern at 2 sites in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Oct 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adjustment Disorder - New Module 20 (ADNM-20) (time frame: 4-week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Oct 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in